SOPHiA GENETICS (SOPH) Debt Ratio (2020 - 2025)
SOPHiA GENETICS (SOPH) reported Debt Ratio of 0.29 for Q4 2025, up 243.52% on a YoY basis from 0.09 in Q4 2024, and up 0.58% sequentially from 0.29 in Q3 2025.
SOPHiA GENETICS (SOPH) Debt Ratio (2020 - 2025) Analysis & Trends
SOPHiA GENETICS (SOPH) has 3 years of Debt Ratio data on file, last reported at 0.29 in Q4 2025.
- For the quarter ending Q4 2025, Debt Ratio rose 243.52% year-over-year to 0.29; the trailing twelve-month figure through Dec 2025 stood at 0.29 (up 243.52% YoY), and the FY2025 full-year result was 0.29, up 243.52% from the prior year.
- Debt Ratio grew to 0.29 in Q4 2025, from 0.29 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.29 in Q4 2025 to a low of 0.07 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 0.40 |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 0.29 |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | - |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | - |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 0.25 |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | - |
| 10 | SOPHiA GENETICS | 408.62 Mn | 338.33 Mn | 14.69 Mn | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.29 |
| Jun 30, 2025 | 0.27 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.07 |
| Dec 31, 2020 | 0.03 |